Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Luigi Barrea(Pegaso University), Silvia Savastano(University of Naples Federico II), Giuseppe Annunziata(Pegaso University), Giovanna Muscogiuri(Federico II University Hospital), Maria Maisto(University of Naples Federico II), Giulia de Alteriis(Federico II University Hospital), Gian Carlo Tenore(University of Naples Federico II), Carolina Di Somma(University of Naples Federico II), Daniela Laudisio(Federico II University Hospital), Annamaria Colao(Federico II University Hospital)
Cited by 258
Related Papers
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Complications of Cushing's syndrome: state of the art
|The Lancet Diabetes & Endocrinology|2016|602
Nutritional recommendations for CoVID-19 quarantine
|European Journal of Clinical Nutrition|2020|548
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
|Theranostics|2019|434